ARTICLE
Volume 10,Issue 7
4 August 2025
TCT for Atypical Glandular Epithelium in 1 Case and Clinical Analysis
Wenling Song ,
Miao Tian
Show Less
1
Postgraduate student of Obstetrics and Gynecology, Bethune Second Clinical College of Jilin University 2023, Jilin University, Changchun 130041, Jilin, China,
2
Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun 130041, Jilin, China,
JCNR 2025 , 9(7), 130–136;
https://doi.org/10.26689/jcnr.v9i7.11460
© 2025 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract
Objective: Cervical adenocarcinoma (ECA) screening has low sensitivity and is prone to missed diagnoses. By analyzing a case of atypical glandular epithelium on TCT, this study aims to improve the clinical diagnosis and treatment of such diseases. Methods: The clinical examination findings, laboratory tests, and diagnostic process of a case with atypical glandular epithelium on TCT were analyzed. Results: The patient was diagnosed with cervical adenocarcinoma. Preoperative symptoms and imaging studies suggested the possibility of adenocarcinoma, and postoperative pathology confirmed the diagnosis of cervical adenocarcinoma (ECA). Conclusion: Through the analysis of this case, we aim to improve the clinical diagnosis and treatment of this condition.
References
Li J, Sun X, Zhao C, et al., 2020, Challenges to Cervical Adenocarcinoma Screening. Chinese Clinical Journal of Obstetrics and Gynecology, 21(2): 212–215. doi:10.13390/j.issn.1672-1861.2020.02.031
Dong L, Qiao Y, 2016, Cervical Adenocarcinoma and HPV. Journal of Practical Obstetrics and Gynecology, 32(8): 561–562.
Cheng Y, Xie X, 2016, Screening for Cervical Adenocarcinoma. Journal of Practical Obstetrics and Gynecology, 32(8): 3. doi:CNKI:SUN:SFCZ.0.2016-08-003
Simona S, Lien H, Soslow RA, 2019, Recent Advances in Invasive Adenocarcinoma of the Cervix. Virchows Archiv, 475(5): 537–549.
Zhong L, Zhou Q, Wang H, et al., 2021, Analysis of the Prognostic Correlation Between HPV Infection and Special Types of Cervical Adenocarcinoma. Journal of Chongqing Medical University, 46(6): 700–703. doi:10.13406/j.cnki.cyxb.002826
Liu Y, Kong W, 2017, Progress in the Treatment of Cervical Adenocarcinoma. Chinese Journal of Reproductive Health, 28(1): 91–93.
Koh WJ, Abu-Rustum NR, Bean S, et al., 2019, Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17(1): 64–84.
Stolnicu S, Barsan I, Hoang L, et al., 2018, International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix. The American Journal of Surgical Pathology, 42(2): 214–226.
Lu S, Shen D, 2021, Update and Interpretation of the 5th Edition of the WHO Classification of Tumors of the Female Genital Organs. Chinese Journal of Obstetrics and Gynecology, 56(8): 5. doi:10.3760/cma.j.cn112141-20210518-00273
Shi H, Lu B, Lu W, 2022, Pathologic Classification of Adenocarcinoma of the Uterine Cervix. Chinese Medical Journal, 102(26): 2045–2049. doi:10.3760/cma.j.cn112137-20211026-02361
Hohn AK, Brambs CE, Hiller GGR, et al., 2021, 2020 WHO Classification of Female Genital Tumors. Geburtshilfe und Frauenheilkunde, 81(10): 1145–1153.
Roma AA, Vivar ADD, Park KJ, et al., 2015, Invasive Endocervical Adenocarcinoma: A New Pattern-Based Classification System With Important Clinical Significance. American Journal of Surgical Pathology, 39(5): 667–672. doi:10.1097/PAS.0000000000000402
Stolnicu S, Hoang L, Chiu D, et al., 2019, Clinical Outcomes of HPV-Associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC). The American Journal of Surgical Pathology, 43(4): 466–474. doi:10.1097/PAS.0000000000001224
Chen L, Hua Y, 2024, Progress of Clinicopathologic Research on Cervical Cancer. Progress in Clinical Medicine, 14(4): 640–647. doi:10.12677/acm.2024.1441071
Roma AA, Mistretta T, Vivar DDA, et al., 2016, New Pattern-Based Personalized Risk Stratification System for Endocervical Adenocarcinoma With Important Clinical Implications and Surgical Outcome. Gynecologic Oncology, 141(1): 36–42.
Abu-Rustum N, Yashar CM, Arend R, et al., 2023, NCCN Guidelines Insights: Cervical Cancer, Version 1.2024. Journal of the National Comprehensive Cancer Network, 21(12): 1224–1233.
Lei C, Yu L, Deng J, et al., 2018, Clinical Significance of Atypical Glandular Cells in Cervical Cytologic Screening. Chinese Journal of Histochemistry and Cytochemistry, 27(4): 350–353. doi:10.16705/j.cnki.1004-1850.2018.04.008
Ma X, Xiang Y, Liu C, et al., 2021, Chinese Expert Consensus on the Diagnosis and Management of Adenocarcinoma in Situ of the Uterine Cervix (2021 Edition). Chinese Journal of Practical Gynecology and Obstetrics, 37(12): 1209–1213. doi:10.19538/j.fk2021120110
Zhao S, Chen H, Zhao F, 2022, A Systematic Review of the Current Status of Global Precancerous Cervical Lesions and Cervical Cancer Treatment Guideline Development. Chinese Medical Journal, 102(22): 11. doi:10.3760/cma.j.cn112137-20211106-02466
Di J, Zhang X, Zhao G, et al., 2024, Interpretation of the Guidelines for Comprehensive Prevention and Control of Cervical Cancer (2nd Edition). Chinese Journal of Maternal and Child Health, 15(2): 1–5. doi:10.19757/j.cnki.issn1674-7763.2024.02.001
Share
Back to top
Bio-Byword Scientific Publishing Pty. Ltd.
We are committed to supporting the scientific community by publishing impactful research and fostering effective communication among scientists. We continuously seek ways to accelerate scientific progress while upholding transparency and open dialogue. Our goal is to make knowledge freely and barrier‑free accessible to all.
Contact us: info@bbwpublisher.com
Level 10, 50 Clarence Street Sydney, NSW 2000 Australia